G. A. Basaran Et Al. , "Benefit from adjuvant anthracyclines according to hormone receptor status," JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15, 2008
Basaran, G. A. Et Al. 2008. Benefit from adjuvant anthracyclines according to hormone receptor status. JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15 .
Basaran, G. A., Cabuk, D., Teomete, M., Gulluoglu, B., KAYA, H., DANE, F., ... YUMUK, P. F.(2008). Benefit from adjuvant anthracyclines according to hormone receptor status. JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15.
Basaran, G. Et Al. "Benefit from adjuvant anthracyclines according to hormone receptor status," JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15, 2008
Basaran, G. A. Et Al. "Benefit from adjuvant anthracyclines according to hormone receptor status." JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15, 2008
Basaran, G. A. Et Al. (2008) . "Benefit from adjuvant anthracyclines according to hormone receptor status." JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15.
@article{article, author={G. Atalay Basaran Et Al. }, title={Benefit from adjuvant anthracyclines according to hormone receptor status}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2008}